Belvedere M, Richiardi P, Curtoni E S, Pellegrino M A, Ferrone S
Immunol Commun. 1979;8(1):93-106. doi: 10.3109/08820137909044710.
Sera from volunteers immunized with planned blood transfusions were tested for anti DR cytotoxic antibodies with a panel of HLA typed cultured human lymphoid cells using a variety of serological techniques. The majority of sera contained DR cytotoxic antibodies. The specificity of DR antibodies in seven sera was determined by testing them with a panel of B peripheral lymphocytes typed with DR alloantisera submitted to the 7th International Histocompatibility Workshop. The temporal evolution of DR and HLA-A and B cytotoxic antibodies was determined in two subjects by testing serial bleedings with B lymphoid cells, coated with Fab2 fragments from anti beta 2 mu and anti DR xenoantisera. Results indicated a parallel evolution of DR and HLA-A and B cytotoxic antibodies.
使用多种血清学技术,用一组经HLA分型的培养人淋巴细胞,对因计划输血而免疫的志愿者的血清进行抗DR细胞毒性抗体检测。大多数血清含有DR细胞毒性抗体。通过用一组经第7届国际组织相容性研讨会提交的DR同种异体抗血清分型的B外周淋巴细胞对7份血清进行检测,确定了DR抗体的特异性。通过用抗β2微球蛋白和抗DR异种抗血清的Fab2片段包被的B淋巴细胞对两名受试者的系列采血进行检测,确定了DR以及HLA - A和B细胞毒性抗体的时间演变。结果表明DR以及HLA - A和B细胞毒性抗体呈平行演变。